Literature DB >> 27587472

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Iris Postmus1, Helen R Warren2,3, Stella Trompet1,4, Benoit J Arsenault5, Christy L Avery6, Joshua C Bis7, Daniel I Chasman8,9, Catherine E de Keyser10, Harshal A Deshmukh11, Daniel S Evans12, QiPing Feng13, Xiaohui Li14, Roelof A J Smit4, Albert V Smith15,16, Fangui Sun17, Kent D Taylor14, Alice M Arnold18, Michael R Barnes2,3, Bryan J Barratt19, John Betteridge20, S Matthijs Boekholdt21, Eric Boerwinkle22, Brendan M Buckley23, Y-D Ida Chen14, Anton J M de Craen1, Steven R Cummings12, Joshua C Denny24,25, Marie Pierre Dubé5, Paul N Durrington26, Gudny Eiriksdottir15, Ian Ford27, Xiuqing Guo14, Tamara B Harris28, Susan R Heckbert29,30,31, Albert Hofman10,32, G Kees Hovingh33, John J P Kastelein33, Leonore J Launer28, Ching-Ti Liu17, Yongmei Liu34, Thomas Lumley7,35, Paul M McKeigue36, Patricia B Munroe2,3, Andrew Neil37, Deborah A Nickerson38, Fredrik Nyberg39,40, Eoin O'Brien41, Christopher J O'Donnell42,43,44, Wendy Post45, Neil Poulter46, Ramachandran S Vasan47, Kenneth Rice18, Stephen S Rich48, Fernando Rivadeneira49, Naveed Sattar50, Peter Sever46, Sue Shaw-Hawkins2,3, Denis C Shields41,51, P Eline Slagboom52, Nicholas L Smith29,31,53, Joshua D Smith38, Nona Sotoodehnia7,54, Alice Stanton55,56, David J Stott57, Bruno H Stricker10,49,58, Til Stürmer6, André G Uitterlinden10,32,49, Wei-Qi Wei24, Rudi G J Westendorp59, Eric A Whitsel6,60, Kerri L Wiggins7, Russell A Wilke61,62, Christie M Ballantyne63, Helen M Colhoun11,64, L Adrienne Cupples17,42, Oscar H Franco10, Vilmundur Gudnason15,16, Graham Hitman65, Colin N A Palmer11, Bruce M Psaty7,29,31,66, Paul M Ridker8, Jeanette M Stafford67, Charles M Stein25,68, Jean-Claude Tardif5, Mark J Caulfield2,3, J Wouter Jukema4,69,70, Jerome I Rotter14, Ronald M Krauss71.   

Abstract

BACKGROUND: In addition to lowering low density lipoprotein cholesterol (LDL-C), statin therapy also raises high density lipoprotein cholesterol (HDL-C) levels. Inter-individual variation in HDL-C response to statins may be partially explained by genetic variation. METHODS AND
RESULTS: We performed a meta-analysis of genome-wide association studies (GWAS) to identify variants with an effect on statin-induced high density lipoprotein cholesterol (HDL-C) changes. The 123 most promising signals with p<1×10-4 from the 16 769 statin-treated participants in the first analysis stage were followed up in an independent group of 10 951 statin-treated individuals, providing a total sample size of 27 720 individuals. The only associations of genome-wide significance (p<5×10-8) were between minor alleles at the CETP locus and greater HDL-C response to statin treatment.
CONCLUSIONS: Based on results from this study that included a relatively large sample size, we suggest that CETP may be the only detectable locus with common genetic variants that influence HDL-C response to statins substantially in individuals of European descent. Although CETP is known to be associated with HDL-C, we provide evidence that this pharmacogenetic effect is independent of its association with baseline HDL-C levels. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Genome-wide association study; HDL-cholesterol; Statins; pharmacogenetics

Mesh:

Substances:

Year:  2016        PMID: 27587472      PMCID: PMC5309131          DOI: 10.1136/jmedgenet-2016-103966

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  37 in total

1.  Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport?

Authors:  Patrick C N Rensen; Louis M Havekes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04       Impact factor: 8.311

2.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

Review 3.  Comparative effects of lipid-lowering therapies.

Authors:  Michael H Davidson; Peter P Toth
Journal:  Prog Cardiovasc Dis       Date:  2004 Sep-Oct       Impact factor: 8.194

4.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

5.  Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Authors:  S Matthijs Boekholdt; Benoit J Arsenault; G Kees Hovingh; Samia Mora; Terje R Pedersen; John C Larosa; K M A Welch; Pierre Amarenco; David A Demicco; Andrew M Tonkin; David R Sullivan; Adrienne Kirby; Helen M Colhoun; Graham A Hitman; D John Betteridge; Paul N Durrington; Michael B Clearfield; John R Downs; Antonio M Gotto; Paul M Ridker; John J P Kastelein
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

6.  Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.

Authors:  Maryse Guerin; Pascal Egger; Céline Soudant; Wilfried Le Goff; Arie van Tol; Reynald Dupuis; M John Chapman
Journal:  Atherosclerosis       Date:  2002-08       Impact factor: 5.162

7.  Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.

Authors:  J Li; L Zhang; N Z Xie; B Deng; L X Lv; L Q Zheng
Journal:  Genet Mol Res       Date:  2014-03-24

8.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

Review 9.  Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.

Authors:  Fergus McTaggart; Peter Jones
Journal:  Cardiovasc Drugs Ther       Date:  2008-06-14       Impact factor: 3.727

10.  Discovery and refinement of loci associated with lipid levels.

Authors:  Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Michael Boehnke; Panos Deloukas; Sekar Kathiresan; Karen L Mohlke; Erik Ingelsson; Gonçalo R Abecasis; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Ron Do; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Åsa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more
  14 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

2.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.

Authors:  Lisanne L Blauw; Raymond Noordam; Sebastian Soidinsalo; C Alexander Blauw; Ruifang Li-Gao; Renée de Mutsert; Jimmy F P Berbée; Yanan Wang; Diana van Heemst; Frits R Rosendaal; J Wouter Jukema; Dennis O Mook-Kanamori; Peter Würtz; Ko Willems van Dijk; Patrick C N Rensen
Journal:  Eur J Hum Genet       Date:  2018-11-12       Impact factor: 4.246

3.  Gene discovery for high-density lipoprotein cholesterol level change over time in prospective family studies.

Authors:  Mary F Feitosa; Kathryn L Lunetta; Lihua Wang; Mary K Wojczynski; Candace M Kammerer; Thomas Perls; Nicole Schupf; Kaare Christensen; Joanne M Murabito; Michael A Province
Journal:  Atherosclerosis       Date:  2020-02-14       Impact factor: 5.162

Review 4.  Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.

Authors:  Elena Arrigoni; Marzia Del Re; Leonardo Fidilio; Stefano Fogli; Romano Danesi; Antonello Di Paolo
Journal:  Int J Mol Sci       Date:  2017-01-06       Impact factor: 5.923

Review 5.  Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.

Authors:  Maria Mytilinaiou; Ioannis Kyrou; Mike Khan; Dimitris K Grammatopoulos; Harpal S Randeva
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

6.  Finding associated variants in genome-wide association studies on multiple traits.

Authors:  Lisa Gai; Eleazar Eskin
Journal:  Bioinformatics       Date:  2018-07-01       Impact factor: 6.937

7.  Gender specific effect of CETP rs708272 polymorphism on lipid and atherogenic index of plasma levels but not on the risk of coronary artery disease: A case-control study.

Authors:  Gaojun Cai; Ganwei Shi; Zhiying Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

Review 9.  Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.

Authors:  Diego Estrada-Luna; María Araceli Ortiz-Rodriguez; Lizett Medina-Briseño; Elizabeth Carreón-Torres; Jeannett Alejandra Izquierdo-Vega; Ashutosh Sharma; Juan Carlos Cancino-Díaz; Oscar Pérez-Méndez; Helen Belefant-Miller; Gabriel Betanzos-Cabrera
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

10.  Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin.

Authors:  Sony Tuteja; Liming Qu; Marijana Vujkovic; Richard L Dunbar; Jinbo Chen; Stephanie DerOhannessian; Daniel J Rader
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.